Literature DB >> 15618835

Overlap syndrome of autoimmune pancreatitis and cholangitis associated with secondary Sjögren's syndrome.

Tilman Pickartz1, Heinz Pickartz, Herbert Lochs, Johann Ockenga.   

Abstract

In approximately 25% of patients with acute or chronic pancreatitis the cause remains unclear. Despite progress in understanding so-called idiopathic pancreatitis, more diagnostic criteria are needed. We report on a patient who presented with jaundice, but without pain or fever. Under the assumption of pancreatic cancer the patient underwent hemipancreatoduodenectomy. Histological examination showed chronic sclerosing inflammation of the pancreas and bile ducts without any signs of malignancy. Ten weeks later he developed bilateral parotid swelling and recurrent bouts of fever. Again liver enzymes were elevated and unsuccessfully treated with antibiotics for bacterial cholangitis. Further biopsies from submandibular gland, lymph nodes and liver again showed chronic sclerosing inflammation with lymphoplasmacytic infiltration. For sicca symptoms the diagnosis of a primary Sjogren's syndrome was proposed. However, with corticosteroid treatment the patient improved remarkably but after tapering he relapsed. On the basis of established criteria, we diagnosed autoimmune pancreatitis with (1) diffuse swelling of the pancreas, (2) irregularities of the pancreatic duct, (3) lymphoplasmacytic infiltration, (4) response to corticosteroids, (5) hypergammaglobulinaemia, and (6) disproportionately raised IgG4. In addition, the patient fulfilled the criteria for secondary Sjogren's syndrome. Autoimmune pancreatitis may present as an isolated or syndromic disease. It is an autoimmune disorder of unknown cause and should be included in the differential diagnosis of pancreatic disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15618835     DOI: 10.1097/00042737-200412000-00010

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  9 in total

1.  [Chronic pancreatitis as a risk factor for the development of pancreatic cancer--diagnostic challenges].

Authors:  Tilman Pickartz; Julia Mayerle; Matthias Kraft; Matthias Evert; Katja Evert; Jens-Peter Kühn; Claus-Dieter Heidecke; Markus M Lerch
Journal:  Med Klin (Munich)       Date:  2010-04

Review 2.  Autoimmune pancreatitis and IgG4-related systemic diseases.

Authors:  Lizhi Zhang; Thomas C Smyrk
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

Review 3.  Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.

Authors:  Ibtisam Al-Hashimi
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Acute recurrent pancreatitis: an autoimmune disease?

Authors:  Raffaele Pezzilli
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

5.  Characteristics of primary Sjögren's syndrome patients with IgG4 positive plasma cells infiltration in the labial salivary glands.

Authors:  Chang Liu; Huayong Zhang; Genhong Yao; Yunxia Hu; Jingjing Qi; Yan Wang; Weiwei Chen; Xiaojun Tang; Wenchao Li; Liwei Lu; Luo Gu; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2016-11-18       Impact factor: 2.980

6.  Autoimmune pancreatitis: functional and morphological recovery after steroid therapy.

Authors:  László Czakó; Eva Hegyközi; Attila Pálinkás; János Lonovics
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

7.  Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis.

Authors:  Hideaki Hamano; Norikazu Arakura; Takashi Muraki; Yayoi Ozaki; Kendo Kiyosawa; Shigeyuki Kawa
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

Review 8.  Hyper-IgG4 disease: report and characterisation of a new disease.

Authors:  Guy H Neild; Manuel Rodriguez-Justo; Catherine Wall; John O Connolly
Journal:  BMC Med       Date:  2006-10-06       Impact factor: 8.775

9.  Primary Sjogren's syndrome and the risk of acute pancreatitis: a nationwide cohort study.

Authors:  Chi-Ching Chang; Yu-Sheng Chang; Shu-Hung Wang; Shyr-Yi Lin; Yi-Hsuan Chen; Jin Hua Chen
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.